Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome--a randomised controlled trial (Q34157411)

31 July 2017

Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome--a randomised controlled trial (English)

1 reference

31 July 2017

0 references

Carl-Gerhard Gottfries

6

object named as

Carl-Gerhard Gottfries

1 reference

31 July 2017

Olof Zachrisson

1

1 reference

31 July 2017

Björn Regland

2

1 reference

31 July 2017

Marianne Jahreskog

3

1 reference

31 July 2017

Michael Jonsson

4

1 reference

31 July 2017

Margareta Kron

5

1 reference

31 July 2017

1 January 2002

1 reference

31 July 2017

European Journal of Pain

1 reference

31 July 2017

6

1 reference

31 July 2017

6

1 reference

31 July 2017

455-466

1 reference

Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Effects of staphylococcus toxoid vaccine on pain and fatigue in patients with fibromyalgia/chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Fibromyalgia and chronic fatigue syndrome: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

An association of membrane-damaging toxins from coagulase-negative staphylococci and chronic orofacial muscle pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Inflammatory response: pathway across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Fibromyalgia syndrome a decade later: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Chronic fatigue syndrome: a working case definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

A community-based study of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Prevalence of chronic fatigue syndrome in a community population in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Neurasthenic symptoms in workers occupationally exposed to jet fuel

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Chronic fatigue syndrome: clinical condition associated with immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Resistance against Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

21 January 2018

Steroids and depression

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Reliability and validity studies of the comprehensive psychopathological rating scale (CPRS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Chronic fatigue syndrome (CFS) associated with Staphylococcus spp. bacteremia, responsive to potassium arsenite 0.5% in a veterinary surgeon and his coworking wife, handling with CFS animal cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Functional somatic syndromes: one or many?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Longitudinal study of outcome of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

The prevalence and characteristics of fibromyalgia in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Which outcome measures should be used in rheumatoid arthritis clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

Comparison of six depression rating scales in geriatric stroke patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

7 January 2021

A comprehensive psychopathological rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

7 January 2021

Responsiveness of functional status in low back pain: a comparison of different instruments

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

7 January 2021

Do infections trigger fibromyalgia?

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

7 January 2021

Co-existence of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1090-3801%2802%2900044-7

7 January 2021

10.1016/S1090-3801(02)00044-7

Identifiers

DOI

1 reference

31 July 2017

1 reference